$KNW
KNOW LABS, INC. Stock $knw

$knw Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-K Financial Statement

#000165495424014480 Filed on November 14, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2024
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin			$9.109M
YoY Change			38.64%
% of Gross Profit
Research & Development			$6.114M
YoY Change			-20.88%
% of Gross Profit
Depreciation & Amortization			$80.88K
YoY Change			-74.16%
% of Gross Profit
Operating Expenses			$15.22M
YoY Change			8.55%
Operating Profit			-$15.22M
YoY Change			8.55%
Interest Expense			$1.513M
YoY Change			288.4%
% of Operating Profit
Other Income/Expense, Net			-$1.358M
YoY Change			7.35%
Pretax Income			-$16.58M
YoY Change			8.45%
Income Tax			$0.00
% Of Pretax Income
Net Earnings			-$16.58M
YoY Change			8.45%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding	108.1M shares	99.62M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q4	2024 Q3	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents		$3.111M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets		$3.111M
YoY Change		-61.23%
LONG-TERM ASSETS
Property, Plant & Equipment		$66.80K
YoY Change		-17.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$553.7K
YoY Change		128.62%
TOTAL ASSETS
Total Short-Term Assets		$3.111M
Total Long-Term Assets		$553.7K
Total Assets		$3.664M
YoY Change		-55.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses		$101.6K
YoY Change		7.99%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$5.163M
YoY Change		14.18%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities		$5.163M
Total Long-Term Liabilities
Total Liabilities		$5.821M
YoY Change		28.72%
SHAREHOLDERS EQUITY
Retained Earnings		-$138.7M
YoY Change		13.87%
Common Stock		$108.0K
YoY Change		34.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		-$2.156M
YoY Change
Total Liabilities & Shareholders Equity		$3.664M
YoY Change		-55.67%

Cashflow Statement

Concept	2024 Q4	2024 Q3	2024
OPERATING ACTIVITIES
Net Income			-$16.58M
YoY Change			8.45%
Depreciation, Depletion And Amortization			$80.88K
YoY Change			-74.16%
Cash From Operating Activities			-$12.83M
YoY Change			23.91%
INVESTING ACTIVITIES
Capital Expenditures			$66.35K
YoY Change			-17.88%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities			-$66.35K
YoY Change			-17.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$5.193M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities			$7.983M
YoY Change			36.11%
NET CHANGE
Cash From Operating Activities			-$12.83M
Cash From Investing Activities			-$66.35K
Cash From Financing Activities			$7.983M
Net Change In Cash			-$4.913M
YoY Change			7.51%
FREE CASH FLOW
Cash From Operating Activities			-$12.83M
Capital Expenditures			$66.35K
Free Cash Flow			-$12.90M
YoY Change			23.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	3743912	usd
CY2024	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	2957559	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	108097936	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80358463	shares
CY2024Q2	knwn	Authorized Shares Of Capital Stock AuthorizedSharesOfCapitalStock	305000000	shares
CY2024Q2	knwn	Authorized Shares Of Capital Common Stock AuthorizedSharesOfCapitalCommonStock	300000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024	us-gaap	Derivatives Methods Of Accounting Hedge Effectiveness DerivativesMethodsOfAccountingHedgeEffectiveness	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Derivative Financial Instruments</em></strong><strong> – </strong>Pursuant to ASC 815 “Derivatives and Hedging”, the Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company then determines if an embedded derivative must be bifurcated and separately accounted for. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determined that the conversion features for purposes of bifurcation within its currently outstanding convertible notes payable were immaterial and there was no derivative liability to be recorded as of September 30, 2024 and 2023.</p>
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Use of Estimates</em></strong> – The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001074828
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	108097936	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	80358463	shares
CY2024	knwn	Sell Shares Of Common Stock SellSharesOfCommonStock	12000000	usd
CY2023Q3	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	80358463	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2024	knwn	Gross Proceed From Public Issue Stock GrossProceedFromPublicIssueStock	3445000.000	usd
CY2024	knwn	Net Proceed From Deducting Issue Stock NetProceedFromDeductingIssueStock	3468000.000	usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-37479
CY2024	dei	Entity Registrant Name EntityRegistrantName	KNOW LABS, INC.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0273142
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	619 Western Avenue
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 610
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Seattle
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98104
CY2024	dei	City Area Code CityAreaCode	206
CY2024	dei	Local Phone Number LocalPhoneNumber	903-1351
CY2024	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2024	dei	Trading Symbol TradingSymbol	KNW
CY2024	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Public Float EntityPublicFloat	49096582	usd
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	108097936	shares
CY2024	dei	Auditor Firm AuditorFirmId	207
CY2024	dei	Auditor Name AuditorName	BPM LLP
CY2024	dei	Auditor Location AuditorLocation	Santa Rosa, California
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3110755	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8023716	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	3110755	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	8023716	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	66796	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	81325	usd
CY2024Q3	us-gaap	Other Assets OtherAssets	149174	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	15766	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	337703	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	145090	usd
CY2024Q3	us-gaap	Assets Assets	3664428	usd
CY2023Q3	us-gaap	Assets Assets	8265897	usd
CY2024Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	552680	usd
CY2023Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1292861	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	101582	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	94062	usd
CY2024Q3	knwn	Amount Due To Related Parties Current AmountDueToRelatedPartiesCurrent	84573	usd
CY2023Q3	knwn	Amount Due To Related Parties Current AmountDueToRelatedPartiesCurrent	218334	usd
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	2855058	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1301005	usd
CY2024Q3	knwn	Convertible Debt Related Parties ConvertibleDebtRelatedParties	1460926	usd
CY2023Q3	knwn	Convertible Debt Related Parties ConvertibleDebtRelatedParties	1460926	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	108560	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	154797	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5163379	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4521985	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	249728	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2024Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	407522	usd
CY2023Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	usd
CY2024Q3	us-gaap	Liabilities Liabilities	5820629	usd
CY2023Q3	us-gaap	Liabilities Liabilities	4521985	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	108021	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	80358	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	136468855	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	125501537	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-138735882	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-121840788	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-2156201	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	3743912	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3664428	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8265897	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6114121	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7727467	usd
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9109362	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6570597	usd
CY2024	knwn	Selling And Transactional Costs For Digital Assets SellingAndTransactionalCostsForDigitalAssets	0	usd
CY2023	knwn	Selling And Transactional Costs For Digital Assets SellingAndTransactionalCostsForDigitalAssets	-274019	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	15223483	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	14024045	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-15223483	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-14024045	usd
CY2024	us-gaap	Interest Income Other InterestIncomeOther	155248	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	127145	usd
CY2024	us-gaap	Interest Expense InterestExpense	1513323	usd
CY2023	us-gaap	Interest Expense InterestExpense	389626	usd
CY2024	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-506865	usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-495776	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1358075	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1265122	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16581558	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15289167	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-16581558	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15289167	usd
CY2024	us-gaap	Dividends Preferred Stock DividendsPreferredStock	313536	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3526653	usd
CY2024	knwn	Common Stock Dividends On Series D Preferred Stock CommonStockDividendsOnSeriesDPreferredStock	0	usd
CY2023	knwn	Common Stock Dividends On Series D Preferred Stock CommonStockDividendsOnSeriesDPreferredStock	1627230	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-16895094	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-20443050	usd
CY2024	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.20
CY2023	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.41
CY2024	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	86067999	shares
CY2023	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	49581467	shares
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9862613	usd
CY2023	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	2955933	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4687	usd
CY2023	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	387334	usd
CY2023	knwn	Common Stock Dividends On Series D Preferred Stock Amount CommonStockDividendsOnSeriesDPreferredStockAmount	0	usd
CY2023	knwn	Deemed Dividends On Series C And D Preferred Stock DeemedDividendsOnSeriesCAndDPreferredStock	0	usd
CY2023	knwn	Isssuance Of Common Stock For Common Stock Offering Amount IsssuanceOfCommonStockForCommonStockOfferingAmount	5472791	usd
CY2023	knwn	Expenses For Extension Of Notes And Warrants ExpensesForExtensionOfNotesAndWarrants	349721	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15289167	usd
CY2024	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2024	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	197010	usd
CY2024	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	7800	usd
CY2024	knwn	Common Stock Dividends On Series C And D Preferred Stock Amount CommonStockDividendsOnSeriesCAndDPreferredStockAmount	0	usd
CY2024	knwn	Deemed Dividends On Series C And D Preferred Stock DeemedDividendsOnSeriesCAndDPreferredStock	0	usd
CY2024	knwn	Isssuance Of Common Stock For Common Stock Offering Amount IsssuanceOfCommonStockForCommonStockOfferingAmount	5193262	usd
CY2024	knwn	Issuance Of Shares And Warrants In Connection With Debt Offering Amount IssuanceOfSharesAndWarrantsInConnectionWithDebtOfferingAmount	1491052	usd
CY2024	knwn	Expenses For Extension Of Notes And Warrants ExpensesForExtensionOfNotesAndWarrants	594761	usd
CY2024	knwn	Issuance Of Common Stock For Debt Payment Amount IssuanceOfCommonStockForDebtPaymentAmount	240000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-16581558	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-2156201	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-16581558	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-15289167	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	80881	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	313019	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	2957559	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2955933	usd
CY2024	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	277011	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
CY2024	knwn	Gain On Debt Settlement GainOnDebtSettlement	0	usd
CY2023	knwn	Gain On Debt Settlement GainOnDebtSettlement	-50000	usd
CY2024	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-549431	usd
CY2024	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-506865	usd
CY2024	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	189286	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	142840	usd
CY2024	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	830948	usd
CY2023	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	0	usd
CY2024	us-gaap	Interest Expense Other InterestExpenseOther	594761	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	349721	usd
CY2024	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	133408	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1999	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-178408	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-147719	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-866422	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	317085	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12829350	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10353991	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	66352	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	80797	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-66352	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-80797	usd
CY2024	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	3764129	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2024	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	720000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5193262	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5472791	usd
CY2024	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	262450	usd
CY2023	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	0	usd
CY2024	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	7800	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	387334	usd
CY2024	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4687	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7982741	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5864812	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4912961	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4569976	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8023716	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12593692	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3110755	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8023716	usd
CY2024	us-gaap	Interest Paid InterestPaid	241000	usd
CY2023	us-gaap	Interest Paid InterestPaid	140000	usd
CY2024	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2024	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	313536	usd
CY2023	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	3526653	usd
CY2024	knwn	Common Stock Dividends On Series D Preferred Stock CommonStockDividendsOnSeriesDPreferredStock	0	usd
CY2023	knwn	Common Stock Dividends On Series D Preferred Stock CommonStockDividendsOnSeriesDPreferredStock	1627230	usd
CY2024	knwn	Warrants Issued For Debt Offering WarrantsIssuedForDebtOffering	2110731	usd
CY2023	knwn	Warrants Issued For Debt Offering WarrantsIssuedForDebtOffering	0	usd
CY2024	knwn	Issuance Of Common Stock For Debt Payment IssuanceOfCommonStockForDebtPayment	240000	usd
CY2023	knwn	Issuance Of Common Stock For Debt Payment IssuanceOfCommonStockForDebtPayment	0	usd
CY2024	knwn	Issuance Costs From Common Stock Offering IssuanceCostsFromCommonStockOffering	670149	usd
CY2023	knwn	Issuance Costs From Common Stock Offering IssuanceCostsFromCommonStockOffering	1527209	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3110755	usd
CY2024Q3	knwn	Net Working Capital NetWorkingCapital	2052624	usd
CY2024Q3	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	250000	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6114121	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7727467	usd
CY2024	knwn	Severance And Other Expenses SeveranceAndOtherExpenses	405000	usd
CY2023	knwn	Severance And Other Expenses SeveranceAndOtherExpenses	859000	usd
CY2024	us-gaap	Advertising Expense AdvertisingExpense	605830	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	307638	usd
CY2024Q3	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	2941616	usd
CY2023Q3	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	7836393	usd
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	108097936	shares
CY2024Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	27506731	shares
CY2024	knwn	Convertible Debentures ConvertibleDebentures	1961575	usd
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80358463	shares
CY2023Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	14506158	shares
CY2023	knwn	Convertible Debentures ConvertibleDebentures	2761931	usd
CY2024Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	279683	usd
CY2023Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	213330	usd
CY2024Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	21366	usd
CY2023Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	21366	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	234253	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	153371	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	66796	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	81325	usd
CY2024	us-gaap	Depreciation Depreciation	80881	usd
CY2023	us-gaap	Depreciation Depreciation	313019	usd
CY2023Q3	knwn	Assets Net Book Value AssetsNetBookValue	549431	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	358288	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	154797	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	337703	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	145090	usd
CY2024	us-gaap	Lease Cost LeaseCost	136000	usd
CY2023	us-gaap	Lease Cost LeaseCost	268000	usd
CY2024	knwn	Operatingleaseweighted Average Remaining Lease Term OperatingleaseweightedAverageRemainingLeaseTerm	P34M
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07	pure
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	127795	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	143819	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	123389	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	395002	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	36714	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	358288	usd
CY2024Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	4723506	usd
CY2023Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2761931	usd
CY2024Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	407522	usd
CY2023Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2024Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	4315984	usd
CY2023Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2761931	usd
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	4723506	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2761931	usd
CY2024	knwn	Note Shares And Warrant Shares Upon Repayment Or Conversion Of Notes And Exercise Of Warrants Description NoteSharesAndWarrantSharesUponRepaymentOrConversionOfNotesAndExerciseOfWarrantsDescription	Issuance of note shares and warrant shares upon repayment or conversion of notes and exercise of warrants is subject to an ownership limitation equal to 4.99% of our outstanding shares of common stock; provided, that if Lind and its affiliates beneficially own in excess of 4.99% of our outstanding shares of common stock, then such limitation shall automatically increase to 9.99% so long as Lind and its affiliates own in excess of 4.99% of such common stock (and shall, for the avoidance of doubt, automatically decrease to 4.99% upon Lind and its affiliates ceasing to own in excess of 4.99% of such common stock)
CY2024	us-gaap	Interest Expense Debt InterestExpenseDebt	250000	usd
CY2024	us-gaap	Recapitalization Costs RecapitalizationCosts	15000000	usd
CY2024	knwn	Securities Purchase Agreement Description SecuritiesPurchaseAgreementDescription	the Company incurred approximately $994,000 of issuance costs of which $557,000 were allocated to the note and $437,000 to the warrant shares. The amount allocated to the notes was recorded as debt discount (with an offset to APIC) and will be amortized over the two-year term of the notes
CY2024	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	830948	usd
CY2024	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	546697	shares
CY2024Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.44
CY2024Q3	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	240000	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024	knwn	Promissory Notes Convertible Into Common Stock PromissoryNotesConvertibleIntoCommonStock	9020264	shares
CY2024	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	7634381	shares
CY2024	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	197010	usd
CY2024Q1	knwn	Description Of Automatic Conversion Of Convertible DescriptionOfAutomaticConversionOfConvertible	the Company issued 102,302 shares of the Company’s common stock at $0.782 with a total value of $80,000 related to a debt offering. The $80,000 was recorded as debt issuance costs and is being amortized over the two-year term of the debt
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3201534	shares
CY2024Q3	knwn	Number Of Common Stock Shares Settled NumberOfCommonStockSharesSettled	6365385	shares
CY2024Q3	knwn	Exercise Price ExercisePrice	0.26
CY2024Q3	knwn	Gross Proceed From Public Issue Stock GrossProceedFromPublicIssueStock	1655000	usd
CY2024Q3	knwn	Net Proceed From Deducting Issue Stock NetProceedFromDeductingIssueStock	1515000	usd
CY2024Q1	knwn	Interest Expense As Incremental Cost InterestExpenseAsIncrementalCost	594761	usd
CY2024	knwn	Aggregate Principal Amount AggregatePrincipalAmount	1987500	usd
CY2024	knwn	Interest Expense As Incremental Cost InterestExpenseAsIncrementalCost	194019	usd
CY2023Q3	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Numbers ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumbers	20866313	shares
CY2023Q3	knwn	Outstanding At Begenning Of Period OutstandingAtBegenningOfPeriod	1.06
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	29679033	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.37
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	853328	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.25
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	350157	shares
CY2024	knwn	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInWeightedAverageExercisePrice	0.42
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2024	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Numbe ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumbe	49341861	shares
CY2024Q3	knwn	Outstanding At End Of Period OutstandingAtEndOfPeriod	0.66
CY2024	knwn	Exercisable At End Of Period ExercisableAtEndOfPeriod	49341861	shares
CY2024Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	49341861	shares
CY2024	knwn	Weighted Averages Remaining Life Years WeightedAveragesRemainingLifeYears	P2Y6M
CY2024Q3	knwn	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePriceBeginningBalance1	0.66
CY2024Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	49341861	shares
CY2024Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	0.66
CY2024	srt	Federal Funds Sold Average Yield FederalFundsSoldAverageYield	0	pure
CY2024	knwn	Stock Price StockPrice	0.37
CY2024	knwn	Exercise Price ExercisePrice	0.37
CY2024	knwn	Expected Life ExpectedLife	P3Y
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	1.07	pure
CY2024	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	49341861	usd
CY2024	knwn	Sharebased Compensation Arrangements By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementsBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	1035393	usd
CY2024Q3	knwn	Share Based Compensation Shares Authorized Under Stocks Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStocksOptionPlansExercisePriceRangeNumberOfOutstandingOptions	27506731	shares
CY2024	knwn	Weighted Average Remaining Life Years WeightedAverageRemainingLifeYears	P3Y5M8D
CY2024Q3	knwn	Weighted Average Exercise Price Outstanding WeightedAverageExercisePriceOutstanding	0.81
CY2024Q3	knwn	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Numbers Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumbersOfExercisableOptions	11477211	shares
CY2024Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	0.83
CY2024	knwn	Stock Option Grants StockOptionGrants	27506731	shares
CY2024	knwn	Intrinsic Value IntrinsicValue	306899	usd
CY2017Q2	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	2908	usd
CY2017Q2	knwn	Lease Description LeaseDescription	The Company vacated the office on May 31, 2024
CY2021Q2	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	8697	usd
CY2021Q2	knwn	Lease Description LeaseDescription	the lease was terminated on February 5, 2024
CY2021Q4	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	5000	usd
CY2021Q4	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2023-12-31
CY2022Q4	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	2250	usd
CY2022Q4	knwn	Lease Description LeaseDescription	The Company vacated the office on May 31, 2024
CY2024Q1	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	11492	usd
CY2024Q1	knwn	Lease Description LeaseDescription	increases at 3% annually after year one. The lease commenced on May 1, 2024 and terminates on July 31, 2027
CY2024	knwn	Losses Arising From United States Taxable LossesArisingFromUnitedStatesTaxable	9000000	usd
CY2023	knwn	Losses Arising From United States Taxable LossesArisingFromUnitedStatesTaxable	4200000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	5900000	usd
CY2024	knwn	Federal Net Operating Loss Carryforwards Expired FederalNetOperatingLossCarryforwardsExpired	expire in 2028-2044
CY2024	knwn	Effective Tax Rate EffectiveTaxRate	1	pure
CY2024Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	17400000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	14200000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	12399000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10476000	usd
CY2024Q3	knwn	Deferred Tax Assets Operating Loss Carryforwards Stock Based Compensation DeferredTaxAssetsOperatingLossCarryforwardsStockBasedCompensation	2671000	usd
CY2023Q3	knwn	Deferred Tax Assets Operating Loss Carryforwards Stock Based Compensation DeferredTaxAssetsOperatingLossCarryforwardsStockBasedCompensation	2174000	usd
CY2024Q3	knwn	Deferred Tax Assets Operating Loss Carryforwards Research And Development DeferredTaxAssetsOperatingLossCarryforwardsResearchAndDevelopment	2292000	usd
CY2023Q3	knwn	Deferred Tax Assets Operating Loss Carryforwards Research And Development DeferredTaxAssetsOperatingLossCarryforwardsResearchAndDevelopment	1460000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	0	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	0	usd
CY2024Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	18000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	46000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17380000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	14156000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17380000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14156000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3224000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2789000	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.01	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.01	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.20	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.18	pure
CY2024	knwn	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Other And Prior Year True Up EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsOtherAndPriorYearTrueUp	0	pure
CY2023	knwn	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Other And Prior Year True Up EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsOtherAndPriorYearTrueUp	0.02	pure
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure

Files In Submission

Name	View Source	Status
0001654954-24-014480-index-headers.html	Edgar Link	pending
0001654954-24-014480-index.html	Edgar Link	pending
0001654954-24-014480.txt	Edgar Link	pending
0001654954-24-014480-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
knwn-20240930.xsd	Edgar Link	pending
knwn_10k.htm	Edgar Link	pending
knwn_ex19.htm	Edgar Link	pending
knwn_ex211.htm	Edgar Link	pending
knwn_ex311.htm	Edgar Link	pending
knwn_ex312.htm	Edgar Link	pending
knwn_ex321.htm	Edgar Link	pending
knwn_ex322.htm	Edgar Link	pending
knwn_ex42.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
knwn-20240930_cal.xml	Edgar Link	unprocessable
knwn-20240930_pre.xml	Edgar Link	unprocessable
knwn-20240930_lab.xml	Edgar Link	unprocessable
knwn_10k_htm.xml	Edgar Link	completed
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
knwn-20240930_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KNW
KNOW LABS, INC. Stock $knw

2024 Q4 Form 10-K Financial Statement

#000165495424014480 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KNW KNOW LABS, INC. Stock $knw

2024 Q4 Form 10-K Financial Statement

#000165495424014480 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KNW
KNOW LABS, INC. Stock $knw